Imatinib Mesylate

Rediff.com » News » Imatinib Mesylate

News for Imatinib Mesylate

Business

Dr Reddy's A-team moves on putting house in order

After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set......

Sun Pharma sues Novartis in US court

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New......

Domestic pharma lauds apex court verdict

Though the India office here of Swiss pharma giant Novartis wore a gloomy look following the Supreme Court rejection of its Glivec patent application, Indian pharmaceutical companies and......

Will not invest on R&D in India, says Novartis

Swiss pharma major Novartis said on Monday it will not invest on research and development in India and move R&D to favourable destinations following the Supreme Court order rejecting its patent......

Markets settle near 3-week low; ITC tanks nearly 7%

Markets closed lower for the fourth session closing near three-week low with ITC contributing the most to the decline after Arvind Subramanian-led GST panel suggested that tobacco products......

Rediff News

Imatinib Mesylate

News for Imatinib Mesylate

Dr Reddy's A-team moves on putting house in order

Sun Pharma sues Novartis in US court

Domestic pharma lauds apex court verdict

Will not invest on R&D in India, says Novartis

Markets settle near 3-week low; ITC tanks nearly 7%

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS